Home LiteratureArticle Details
PMID: 11023138 Published · ppublish English Journal Article

Clinical characteristics of type 1 diabetic patients with and without severe hypoglycemia.

Diabetes care ·Vol. 23 ·No. 10 ·2000-10-00 ·Pages 1467-71

ter Braak EW, Appelman AM, van de Laak M, Stolk RP, van Haeften TW, Erkelens DW

Abstract

To investigate the frequency of severe hypoglycemia (SH) and hypoglycemic coma and to identify clinical and behavioral risk indicators in a nonselected population of type 1 diabetic patients. This study involved a retrospective clinical survey of 195 consecutive patients using a questionnaire addressing the frequency of SH (i.e., help from others required) and hypoglycemic coma during the previous year, general characteristics, behavior, hypoglycemia awareness, and the Hypoglycemia Fear Survey Data regarding diabetes, treatment, long-term complications, comorbidity, and comedication were obtained from the patients' medical records. A total of 82% of subjects were receiving intensive insulin treatment, and mean +/- SD HbA(1c) was 7.8 +/- 1.2%. Mean duration of diabetes was 20 +/- 12 years. The occurrence of SH (including hypoglycemic coma) was 150 episodes/100 patient-years and affected 40.5% of the population. Hypoglycemic coma occurred in 19% of subjects (40 episodes/100 patient-years). SH without coma was independently related to nephropathy (odds ratio [OR] 4.8 [95% CI 1.5-15.1]), a threshold for hypoglycemic symptoms of <3 mmol/l (4.8 [1.8-12.0]), and a daily insulin dose 0.1 U/kg higher (1.3 [1.0-1.6]) (all ORs were adjusted for diabetes duration and use of comedication). Hypoglycemic coma was independently related to neuropathy (3.9 [1.5-10.4]), (nonselective) beta-blocking agents (14.9 [2.1-107.4]), and alcohol use (3.5 [1.3-9.1]) (all ORs were adjusted for diabetes duration). SH and hypoglycemic coma are common in a nonselected population with type 1 diabetes. The presence of long-term complications, a threshold for symptoms of <3 mmo/l, alcohol use, and (nonselective) beta-blockers were associated with SH during the previous year. If prospectively confirmed, these results may have consequences for clinical practice.

MeSH Terms
Adult Awareness Blood Glucose/metabolism Body Mass Index Diabetes Mellitus, Type 1/blood,drug therapy,physiopathology Diabetic Angiopathies/physiopathology Diabetic Nephropathies/physiopathology Diabetic Neuropathies/physiopathology Diabetic Retinopathy/physiopathology Female Glycated Hemoglobin A/analysis Humans Hypoglycemia/chemically induced,epidemiology,physiopathology Hypoglycemic Agents/adverse effects Insulin/adverse effects Insulin Coma/epidemiology,physiopathology Male Middle Aged Odds Ratio Retrospective Studies Surveys and Questionnaires
Chemicals
Blood Glucose Glycated Hemoglobin A Hypoglycemic Agents Insulin
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
ter Braak E W
Department of Internal Medicine, University Medical Center, Utrecht, The Netherlands.
Appelman A M
van de Laak M
Stolk R P
van Haeften T W
Erkelens D W
Article Info
Journal
Diabetes care
Abbr.
Diabetes Care
ISSN
0149-5992
Published
2000-10-00
Pages
1467-71
Language
English
Region
United States
NLM ID
7805975
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com